#EFIC2025 Latest Industry Innovations
Thursday, 24 April 2025
12.30-14.00 CET – Forum 1
Neuropathic Pain: Pain Intensity and Beyond
Moderator: Ralf Baron
- Risk factors and biopsychosocial determinants for neuropathic pain, Prof. Crombez
- Understanding the impact beyond pain with a topical TRPV1 agonist for PNP: Clinical trial data, Prof. Viel
- The impact beyond pain in pDPN: Benefits of topical treatment, Dr Kender
This Grünenthal symposium, titled ‘Neuropathic Pain: Pain Intensity and Beyond’, explores the multifaceted nature of neuropathic pain, extending beyond pain intensity to broader biopsychosocial impacts on patients. The symposium will be introduced and moderated by Prof. Ralf Baron. The first presentation, led by Prof. Geert Crombez, will discuss the risk factors and biopsychosocial determinants for neuropathic pain, providing insights on the psychosocial and lifestyle factors that influence pain perception and the implications for clinical practice. The second presentation, led by Prof. Eric Viel, will highlight clinical trial data that showcases the impact of a topical TRPV1 agonist on pain and biopsychosocial variables in patients with peripheral neuropathic pain. The final presentation, led by Dr Zoltan Kender, will discuss the disease background of painful diabetic peripheral neuropathy (pDPN), the impact on patients and the benefits of topical treatment for pDPN. Together, these presentations aim to offer a comprehensive perspective on the biopsychosocial impact of neuropathic pain and the impacts of topical TRPV1 agonist treatment.
This Symposium is organised and supported by:
12.30-14.00 CET – Pasteur Lounge
Introducing Haleon Pain Management Institute. A deep dive into the patient journey – Is Pain an accelerator of ageing?
- HPMI Introduction, Mukesh Kumar (Global Expert lead OTC, Haleon) – 15 minutes
- Predictors of Pain across ages, Dr Preeti Kachroo (Global Medical & Scientific Affairs Director OTC, Haleon) – 15 minutes
- Pain is accelerator of age, Dr. Serge Perrot (Rheumatologist and Pain Specialist at Cochin Hospital, Université Paris Cité, France) – 20 minutes
- Panel discussion, Dr. Serge Perrot & Dr Preeti Kachroo – 20 minutes
Description: As per the Haleon Pain Index, a social study on the global assessment of the state of pain in the world – 59% of people living in pain suffer deep feelings of social isolation , 49% feel stigmatized due to pain and 6 in 10 wish their pain was better accepted by society. The Haleon Pain Management Institute (HPMI) is an initiative by Haleon to advance the science and understanding of pain for improved pain management and patient outcomes. By collaborating with multidisciplinary experts, HPMI aims to enhance pain management through education and skills development for frontline care experts, deepening patient understanding and behaviour change knowledge, and building scientific credentials through partnerships and research.
Pain is not just a symptom of the aging process. It also significantly influences how we age. In the session on Pain & Age we will discover the impact and causes that accelerate aging at biological and functional level.
This Symposium is organised and supported by:
Friday, 25 April 2025
12.35-14.00 CET – Forum 1
Beyond pain phenotypes: dissecting mixed pain
Moderator: Prof. Rainer Freynhagen
- Missunderstandings and potential opportunities: not all pain is created equal, Rainer Freynhagen, Munich, Germany (15 minutes)
- Sensory profiles and phenotypes: the never-ending search for distinctive mechanisms, Daniel Ciampi de Andrade, Aalborg, Denmark (15 minutes)
- Why clinical skills matter: the vital importance of providing an accurate diagnosis, Ralf Baron, Kiel, Germany (15 minutes)
- How to unleash the potential of an effective medication management, Bart Morlion, Leuven, Belgium (15 minutes)
- Open Discussion (25 minutes)
This Symposium is organised and supported by:
12.35-13.55 CET – Forum 2
Cannabis-based medicines in chronic low back pain: Where Do We Stand?
Moderator: Prof. Nadine Attal (Boulogne Billancourt, France)
- Challenges in the pharmacological treatment of chronic low back pain, Prof. Serge Perrot, Paris, France (15 minutes)
- Systematic reviews on cannabis-based medicines for chronic pain: A methodological and political minefield, Prof. Winfried Häuser, Saarbrücken, Germany (20 minutes)
- Pivotal phase 3 data on the efficacy and safety of VER-01 in chronic low back pain, Prof. Winfried Meißner, Jena, Germany (20 minutes)
- What is the perspective for cannabis-based medicines in the management of chronic low back pain? Prof. Serge Perrot, Prof. Winfried Häuser, Prof. Winfried Meißner (25 minutes)
This Symposium is organised and supported by:
12.45-13.45 CET – Pasteur Lounge
EXOPULSE MOLLII SUIT – a new multisite transcutaneous electrostimulation device: technical aspect, mechanisms of action and effects on diffuse pain
- Speaker 1: Samar S. Ayache
Institut de la Colonne Vértébrale et des NeuroSciences (ICVNS), Paris, France
EA4391 Excitabilité Nerveuse & Thérapeutique, Université Paris Est Créteil, France
Department of Neurology, Gilbert and Rose-Marie Chagoury School of Medicine, Byblos, Lebanon
Unité de Neurophysiologie Clinique, DMU FIxIT, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (APHP), Créteil, France
- Speaker 2: Joseph G. Mattar
Institut de la Colonne Vértébrale et des NeuroSciences (ICVNS), Paris, France
Excitabilité Nerveuse & Thérapeutique, Université Paris Est Créteil, France
Description : TENS has shown benefits in pain management1,2, though has challenges at home or in clinical practice. “Classic” TENS, with only two or four electrodes, usually does not meet patients’ expectations, especially those suffering from diffuse, hemibody, or bilateral lower limb pain.
Hence, Exopulse Mollii Suit – an innovative noninvasive electrostimulation device – composed of a control unit and garments, with fifty-eight embedded electrodes, represents an attractive nonpharmacological approach to reduce pain and optimize motor functions.
We will present the technical aspects, mechanisms of action, and recent studies results on diffuse pain, followed by a practical demonstration of the device.
This workshop is organised and supported by:
Saturday, 26 April 2025
12.45-13.45 CET – Forum 2
Advancing Pain Therapy: The Clinical Impact of Once-Daily Prelonged-Release Pregabalin
Moderator: Prof. Dr. Rainer Freynhagen
- Beyond Immediate-Release: Mechanisms, Advantages & Clinical Considerations, Dr. Rainer Freynhagen, Center for Anesthesiology, Intensive Care & Pain Medicine, Pain Center Starnberger See, Benedictus Hospitals Tutzing and Feldafing & Technical University of Munich, Germany
- Balancing Efficacy and Safety: Smarter Dosing, Better Outcomes?, Dr. Ralf Baron, Department of Neurology, Neurological Pain Research and Therapy, University Hospital Schleswig-Holstein, Kiel, Germany
This Symposium is organised and supported by:
12.30-14.00 CET – Saint-Clair 1 (Level 2)
Hands-On Workshop: Interventional Neuromodulation for neuropathic pain treatment
- SCS Procedure Simulator: experience the SCS procedure, from anatomical guidance to lead placement, for refractory neuropathic pain management. Lionel Coquard – France, Medtronic
- TDD Catheter Placement: experience the TDD procedure, catheter placement and refill programming, for cancer-related pain management. Aafje Tom Dieck – Germany, Medtronic
- Closed Loop Sensing Technology: discover the latest advancements in automated SCS dose delivery through a live programming session. Lucien Talvard – France, Medtronic
Do you treat patients with refractory neuropathic pain, both cancer and non-cancer related? Are you struggling to achieve optimal therapy outcomes and minimum side-effects with conventional medical management? Do you wish to expand your knowledge about non-pharmacological neuromodulation procedures and innovative patient follow-up?
During EFIC 2025, Interventional neuromodulation comes to you!
What to expect:
- Rotate through 3 interactive simulation stations
- Receive hands-on guidance from Therapy Experts
- Learn procedural techniques, anatomical insights, technical considerations and the latest technological advancements in implantable neuromodulation
This Hands-On-Workshop is organised and supported by:
